Evidence map›Paper›PMID 39226551›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2024

Molecularly Engineered Alicyclic Organic Spacers for 2D/3D Hybrid Tin-based Perovskite Solar Cells.

Jinhyeok Choi, Jimin Kim, Minyoung Jeong, Byeongchan Park, Seunghyun Kim, Jisang Park, Kilwon Cho

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jinhyeok ChoiDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Jimin KimDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Minyoung JeongDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Byeongchan ParkDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Seunghyun KimDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Jisang ParkDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.
Kilwon ChoDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, 37673, South Korea.ORCID https://orcid.org/0000-0003-0321-3629

Funding

Korea governmentMinistry of Science and ICTNational Research Foundation of Korea 2020R1A2C3004477National Supercomputing Center KSC-2023-CRE-0086
6 · The paper itself

Abstract

The high defect density and inferior crystallinity remain great hurdles for developing highly efficient and stable Sn-based perovskite solar cells (PSCs). 2D/3D heterostructures show strong potential to overcome these bottlenecks; however, a limited diversity of organic spacers has hindered further improvement. Herein, a novel alicyclic organic spacer, morpholinium iodide (MPI), is reported for developing structurally stabilized 2D/3D perovskite. Introducing a secondary ammonium and ether group to alicyclic spacers in 2D perovskite enhances its rigidity, which leads to increased hydrogen bonding and intermolecular interaction within 2D perovskite. These strengthened interactions facilitate the formation of highly oriented 2D/3D perovskite with low structural disorder, which leads to effective passivation of Sn and I defects. Consequently, the MP-based PSCs achieved a power conversion efficiency (PCE) of 12.04% with superior operational and oxidative stability. This work presents new insight into the design of organic spacers for highly efficient and stable Sn-based PSCs.

Indexed as

2D/3D heterostructuresdefect passivationhydrogen bondingrigiditytin‐based perovskite solar cells

Identifiers

PMID39226551
PMCPMC11600702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.